Eloxx Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of novel ribonucleic acid-modulating drug candidates. It focuses on the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Arlington, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
10
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Eloxx Pharmaceuticals Inc market cap is $43.69M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Eloxx Pharmaceuticals Inc 52 week high is $23.40 as of November 22, 2026.
Eloxx Pharmaceuticals Inc stock price today is $10.69.
Eloxx Pharmaceuticals Inc stock price yesterday was $10.65.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Eloxx Pharmaceuticals Inc P/B ratio is 1.0637.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Eloxx Pharmaceuticals Inc 50-day moving average is $14.02.